CHO Pharma, Inc. (TPEX:6586)
Taiwan · Delayed Price · Currency is TWD 53.80
-3.40 (-5.94%)
May 8, 2026, 2:00 PM CST
CHO Pharma Market Cap
CHO Pharma has a market cap or net worth of 11.68 billion as of May 8, 2026. Its market cap has increased by 23.67% in one year.
Market Cap
11.68B
Enterprise Value
9.64B
Revenue
1.43M
Ranking
n/a
PE Ratio
n/a
Stock Price
53.80
Market Cap Chart
Since September 27, 2017, CHO Pharma's market cap has decreased from 15.00B to 11.68B, a decrease of -22.10%. That is a compound annual growth rate of -2.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 11.68B | 94.31% |
| Dec 31, 2025 | 6.01B | -45.44% |
| Dec 31, 2024 | 11.02B | -25.68% |
| Dec 29, 2023 | 14.83B | -41.16% |
| Dec 30, 2022 | 25.20B | 64.15% |
| Dec 30, 2021 | 15.35B | 235.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medigen Vaccine Biologics | 15.96B |
| Polaris Group | 15.13B |
| AP Biosciences | 14.72B |
| EirGenix | 13.72B |
| TaiMed Biologics | 13.58B |
| Ever Supreme Bio Technology | 12.13B |
| Locus Cell | 11.20B |
| Tanvex BioPharma | 10.41B |